Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05518253
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Weijia Fang, MD 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07004712
What this trial is testing

Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06730581
What this trial is testing

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

Who this might be right for
Gastric Cancer Adenocarcinoma MetastaticOvarian CancerBile Duct Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT06589830
What this trial is testing

TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticAdvanced Colorectal Cancer
Suzhou Teligene Ltd. 80
Testing effectiveness (Phase 2)Looking for participantsNCT05684965
What this trial is testing

XTX301 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Xilio Development, Inc. 358
Testing effectiveness (Phase 2)UnknownNCT01237665
What this trial is testing

IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer

Who this might be right for
Rectal Cancer
Ottawa Hospital Research Institute 15
Early research (Phase 1)Ended earlyNCT06560645
What this trial is testing

PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more
Prelude Therapeutics Incorporated 42
Testing effectiveness (Phase 2)UnknownNCT05580445
What this trial is testing

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Shouyao Holdings (Beijing) Co. LTD 114
Not applicableLooking for participantsNCT05523245
What this trial is testing

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 1,700
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757
What this trial is testing

Investigate APL-5125 in Adults With Advanced Solid Tumors

Who this might be right for
Colorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more
Apollo Therapeutics Ltd 100
Early research (Phase 1)Ended earlyNCT02151357
What this trial is testing

Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor

Who this might be right for
Cancer
Standard Chem. & Pharm. Co., Ltd. 17
Not applicableLooking for participantsNCT06524167
What this trial is testing

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 80
Early research (Phase 1)Study completedNCT00047307
What this trial is testing

Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 46
Early research (Phase 1)Study completedNCT00648102
What this trial is testing

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer+2 more
Celldex Therapeutics 36
Early research (Phase 1)Study completedNCT00199875
What this trial is testing

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Who this might be right for
Renal Cell CarcinomaKidney NeoplasmRenal Cancer+1 more
Ludwig Institute for Cancer Research 18
Testing effectiveness (Phase 2)Study completedNCT04704219
What this trial is testing

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Ended earlyNCT03361228
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 5
Testing effectiveness (Phase 2)Looking for participantsNCT07757165
What this trial is testing

The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion Therapy

Who this might be right for
Advanced Metastatic Gastric Cancer
Fudan University 126
Testing effectiveness (Phase 2)UnknownNCT01305967
What this trial is testing

Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
SBPharmaceutical IND, Co., LTD 20
Testing effectiveness (Phase 2)Study completedNCT02795429
What this trial is testing

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma
Novartis Pharmaceuticals 89
Next Page